§ 401.1. Definitions.
The following words and terms, when used in this part, have the following meanings, unless the context clearly indicates otherwise:
Administer or Administration—The introduction of a substance into the body of a horse.
Bleeder—A horse which hemorrhages from the respiratory tract during a race or within 1 hour post-race, or during exercise or within 1 hour of the exercise or as specifically set forth in the Commission’s regulations.
Bleeder List—A tabulation of bleeders to be maintained by the Commission.
Commission Testing Laboratory—The officially accredited laboratory of the Commission designated as the primary laboratory for the detection, confirmation and reporting of primary sample findings.
Controlled substance—A substance included in the five classification schedules of the Controlled Substance Act of 1970 (21 U.S.C.A. § § 801—971).
Controlled therapeutic medication—A medication approved by the Commission or the Association of Racing Commissioners International (ARCI) for which the regulatory analyte concentration in the samples may not exceed specified regulatory limits approved and published by the Commission.
Foreign substances—All prohibited substances except those which exist naturally in the untreated horse at normal physiological concentration.
Furosemide—4-chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid. Also known as Lasix.
Horse—Either Thoroughbred or Standardbred horses registered for racing under the jurisdiction of the Commission and for the purposes of this chapter shall mean stallion, colt, gelding, ridgling, filly or mare.
Hypodermic injection—An injection into or under the skin or mucosa, including intradermal injection, subcutaneous injection, submucosal injection, intramuscular injection, intravenous injection, intra-arterial injection, intra-articular injection, intra-bursal injection, intraocular (intra-conjunctival) injection.
Overage—A finding certified by the Commission Testing Laboratory that a regulatory analyte from a controlled therapeutic medication is present in the sample in an amount that exceeds the regulatory limit or threshold level.
Positive test—A determination by the Standardbred or Thoroughbred Bureau Directors based upon a finding by the Commission Testing Laboratory that a regulatory analyte from a prohibited substance is present in the sample in an amount that exceeds the regulatory limit.
Practicing veterinarian—A private veterinary practitioner licensed by the Commission and authorized to practice at a licensed racetrack facility within this Commonwealth.
Prohibited substance—Any substance, other than controlled therapeutic medication, or vaccine, equine antihelminthic, antibiotic, equine feed supplement, vitamins and minerals (collectively, ‘‘horse health and husbandry products’’), for which the regulatory analyte concentration in samples may not exceed specified regulatory limits published herein.
Race day—The 24-hour period prior to the scheduled post time for the first race.
Regulatory analyte—An analyte or substance identified and, where appropriate, quantified in a specified matrix for regulatory purposes.
Regulatory limit or Threshold level—The concentration of a specified regulatory analyte that has been defined and published by the Racing Medication and Testing Consortium (RMTC) or ARCI and adopted by the Commission provided that exceeding the specified concentration is deemed either an overage or a positive test.
Security area—The area surrounding the security stall delineated by the Commission and controlled by it.
Security stall—The stall assigned by the Commission to a horse on the bleeder list, for occupancy as a prerequisite for receiving bleeder medication, sometimes called the detention stall.
Split sample laboratory—A duly accredited facility approved by the Commission to test split samples.
Test sample—A portion of a biological or bodily substance or fluid, including, but not limited to, tissue, hair, blood or urine obtained from a horse at the direction of the Commission for the purposes of determining the presence or concentration, or both, of regulatory analytes.
No part of the information on this site may be reproduced for profit or sold for profit.
This material has been drawn directly from the official Pennsylvania Code full text database. Due to the limitations of HTML or differences in display capabilities of different browsers, this version may differ slightly from the official printed version.
